# A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects

> **NCT03201978** · PHASE1 · WITHDRAWN · sponsor: **GlaxoSmithKline**

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** GSK2894512 1% CREAM
- **DRUG:** GSK2894512 MATCHING VEHICLE CREAM

## Key facts

- **NCT ID:** NCT03201978
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-12-14
- **Primary completion:** 2018-05-15
- **Final completion:** 2018-05-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The whole project was discontinued within GSK, hence this study was cancelled before enrolment.
- **Last updated:** 2017-11-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03201978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03201978, "A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03201978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*